CD4+CD25+ Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients

Sonia A. Perez; Michael V. Karamouzis; Dimosthenes V. Skarlos; Alexandros Ardavanis; Nectaria N. Sotiriadou; Eleni G. Iliopoulou; Maria L. Salagianni; George Orphanos; Constantin N. Baxevanis; Gerasimos Rigatos; Michael Papamichail

doi:10.1158/1078-0432.ccr-06-2347

CD4+CD25+ Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-2347 ◽

2007 ◽

Vol 13 (9) ◽

pp. 2714-2721 ◽

Cited By ~ 68

Author(s):

Sonia A. Perez ◽

Michael V. Karamouzis ◽

Dimosthenes V. Skarlos ◽

Alexandros Ardavanis ◽

Nectaria N. Sotiriadou ◽

...

Keyword(s):

Breast Cancer ◽

T Cell ◽

Cancer Patients ◽

Regulatory T Cell ◽

Advanced Stage ◽

Breast Cancer Patients ◽

Cell Frequency ◽

Her 2

Download Full-text

Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients

Journal of Advanced Nursing ◽

10.1046/j.1365-2648.2000.01302.x ◽

2000 ◽

Vol 31 (2) ◽

pp. 259-266 ◽

Cited By ~ 2

Author(s):

Beth Strauss

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Cancer Patients ◽

Phase Iii ◽

Advanced Stage ◽

Breast Cancer Patients ◽

Phase Iii Clinical Trials ◽

Her 2

Download Full-text

Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-012-2132-3 ◽

2012 ◽

Vol 135 (2) ◽

pp. 459-467 ◽

Cited By ~ 29

Author(s):

Fangfang Liu ◽

Yaqing Li ◽

Meijing Ren ◽

Xinmin Zhang ◽

Xiaojing Guo ◽

...

Keyword(s):

Breast Cancer ◽

T Cell ◽

Cancer Patients ◽

Regulatory T Cell ◽

Breast Cancer Patients ◽

Prognostic Predictor

Download Full-text

Identification of a regulatory T cell subset that correlates with in vivo and in vitro immune responses in breast cancer patients receiving a CD4-eliciting, HER2 peptide vaccine (AE37)

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2013.07.312 ◽

2013 ◽

Vol 217 (3) ◽

pp. S134

Author(s):

Alfred Francois Trappey ◽

John S. Berry ◽

Mohamed Mursal ◽

Yusuf Jama ◽

Athina Zacharia ◽

...

Keyword(s):

Breast Cancer ◽

T Cell ◽

Immune Responses ◽

Cancer Patients ◽

Regulatory T Cell ◽

Peptide Vaccine ◽

Cell Subset ◽

Breast Cancer Patients

Download Full-text

Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients With Low Tumor HER-2/neu Expression

10.21236/ada430705 ◽

2004 ◽

Author(s):

David Scheinberg

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Treatment Efficacy ◽

Breast Cancer Patients ◽

Her 2

Download Full-text

Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada471552 ◽

2007 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase II Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada533841 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase 2 Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada538840 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Stage Iv ◽

Phase 2 ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Phase 2 Study ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Correlation between ER, PR, HER-2, and Ki-67 with the risk of bone metastases detected by bone scintigraphy in breast cancer patients: A cross sectional study

Annals of Medicine and Surgery ◽

10.1016/j.amsu.2021.102532 ◽

2021 ◽

pp. 102532

Author(s):

Hanif Afkari ◽

Firdian Makrufardi ◽

Basuki Hidayat ◽

Hendra Budiawan ◽

Achmad Hussein Sundawa Kartamihardja

Keyword(s):

Breast Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Bone Scintigraphy ◽

Cross Sectional Study ◽

Breast Cancer Patients ◽

Sectional Study ◽

Ki 67 ◽

Cross Sectional ◽

Her 2

Download Full-text

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

The Breast ◽

10.1016/j.breast.2006.06.008 ◽

2007 ◽

Vol 16 (1) ◽

pp. 86-93 ◽

Cited By ~ 47

Author(s):

A. Rody ◽

T. Karn ◽

R. Gätje ◽

A. Ahr ◽

C. Solbach ◽

...

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Expression Profiling ◽

Topoisomerase Ii ◽

Tumor Response ◽

Breast Cancer Patients ◽

Topoisomerase Ii Alpha ◽

Protein Tau ◽

Her 2

Download Full-text

Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

Value in Health ◽

10.1016/j.jval.2014.08.2318 ◽

2014 ◽

Vol 17 (7) ◽

pp. A642

Author(s):

G. Elsisi ◽

E. Mady ◽

A.A. Abo Taleb

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Economic Evaluation ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her 2

Download Full-text